Hodge S et al. |
Postinoculation PMPA treatment, but not preinoculation immunomodulatory therapy, protects against development of acute disease induced by the unique simian immunodeficiency virus SIVsmmPBj. |
1999 |
J. Virol. |
pmid:10482616
|
Hughes JR et al. |
Blood levels of TGFbeta1 in liver transplant recipients receiving either tacrolimus or micro-emulsified cyclosporine. |
1999 |
Transplantation |
pmid:10480422
|
Fredericks S and Holt DW |
TGF-beta quantitation can be tricky. |
1999 |
Transplantation |
pmid:10480399
|
Chan MA et al. |
Triptolide is more effective in preventing T cell proliferation and interferon-gamma production than is FK506. |
1999 |
Phytother Res |
pmid:10479754
|
Christner C et al. |
Synthesis and cytotoxic evaluation of cycloheximide derivatives as potential inhibitors of FKBP12 with neuroregenerative properties. |
1999 |
J. Med. Chem. |
pmid:10479292
|
Perry SS et al. |
Direct effects of cyclosporin A on proliferation of hematopoietic stem and progenitor cells. |
1999 Jul-Aug |
Cell Transplant |
pmid:10478713
|
Herrero JI et al. |
Conversion of liver transplant recipients on cyclosporine with renal impairment to mycophenolate mofetil. |
1999 |
Liver Transpl Surg |
pmid:10477843
|
Medina J et al. |
Cytokine profile of human bronchoalveolar macrophages and bronchial epithelial cells in response to inhalation particles of the cyclosporine derivative IMM 125. |
1999 |
Inhal Toxicol |
pmid:10477442
|
Hohl CM and Altschuld RA |
FK506 alters sarcoplasmic reticulum calcium release in neonatal piglet cardiac myocytes. |
1999 |
Pediatr. Res. |
pmid:10473047
|
MacFarlane GD et al. |
Analytical validation of the PRO-Trac II ELISA for the determination of tacrolimus (FK506) in whole blood. |
1999 |
Clin. Chem. |
pmid:10471647
|
Holtbäck U and Eklöf AC |
Mechanism of FK 506/520 action on rat renal proximal tubular Na+, K+-ATPase activity. |
1999 |
Kidney Int. |
pmid:10469369
|
Grassberger M et al. |
A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacology. |
1999 |
Br. J. Dermatol. |
pmid:10468798
|
Yokogawa K et al. |
P-glycoprotein-dependent disposition kinetics of tacrolimus: studies in mdr1a knockout mice. |
1999 |
Pharm. Res. |
pmid:10468022
|
Ogino Y et al. |
Comparison of cyclosporin A and tacrolimus concentrations in whole blood between jejunal and ileal transplanted rats. |
1999 |
J. Pharm. Pharmacol. |
pmid:10467956
|
Johnson CE and Truong NM |
Stability and compatibility of tacrolimus and fluconazole in 0.9% sodium chloride. |
1999 Jul-Aug |
J Am Pharm Assoc (Wash) |
pmid:10467814
|
Ivery MT |
A proposed molecular model for the interaction of calcineurin with the cyclosporin A-cyclophilin A complex. |
1999 |
Bioorg. Med. Chem. |
pmid:10465413
|
Shuto H et al. |
Inhibition of GABA system involved in cyclosporine-induced convulsions. |
1999 |
Life Sci. |
pmid:10465348
|
Alexanian AR and Bamburg JR |
Neuronal survival activity of s100betabeta is enhanced by calcineurin inhibitors and requires activation of NF-kappaB. |
1999 |
FASEB J. |
pmid:10463953
|
Wandel C et al. |
P-glycoprotein and cytochrome P-450 3A inhibition: dissociation of inhibitory potencies. |
1999 |
Cancer Res. |
pmid:10463589
|
Arndt C et al. |
Secretion of FK506/FK520 and rapamycin by Streptomyces inhibits the growth of competing Saccharomyces cerevisiae and Cryptococcus neoformans. |
1999 |
Microbiology (Reading, Engl.) |
pmid:10463165
|